Lipoprotein-associated phospholipase A2 predicts cardiovascular events in dialyzed patients

被引：0
|
作者：
Andreana De Mauri
Matteo Vidali
Doriana Chiarinotti
Giorgio Bellomo
Roberta Rolla
机构：
[1] “Maggiore della Carità” University Hospital,Nephrology and Dialysis Unit
[2] Amedeo Avogadro University of Eastern Piedmont,Department of Health Sciences
[3] “Maggiore della Carità” University Hospital,Clinical Chemistry Laboratory
来源：
Journal of Nephrology | 2019年 / 32卷
关键词：
Lipoprotein-associated phospholipase A2; Cardiovascular disease; Hemodialysis; Mortality; Atherosclerosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：283 / 288
页数：5
相关论文
共 50 条
  • [21] Lipoprotein-Associated Phospholipase A2 Activity Predicts Progression of Subclinical Coronary Atherosclerosis
    Kinney, Gregory L.
    Snell-Bergeon, Janet K.
    Maahs, David M.
    Eckel, Robert H.
    Ehrlich, James
    Rewers, Marian
    Hokanson, John E.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2011, 13 (03) : 381 - 387
  • [22] Lipoprotein-Associated Phospholipase A2 and Risk of Carotid Atherosclerosis and Cardiovascular Events in Community-Based Older Adults in China
    Wang, Chunxiu
    Fang, Xianghua
    Hua, Yang
    Liu, Yutong
    Zhang, Zhongying
    Gu, Xiang
    Wu, Xiaoguang
    Tang, Zhe
    Guan, Shaochen
    Liu, Hongjun
    Liu, Beibei
    Guo, Xiuhai
    Ji, Xunming
    ANGIOLOGY, 2018, 69 (01) : 49 - 58
  • [23] Lipoprotein-Associated Phospholipase A2, a Novel Cardiovascular Inflammatory Marker, in HIV-Infected Patients
    Mangili, Alexandra
    Ahmad, Raabia
    Wolfert, Robert L.
    Kuvin, Jeffrey
    Polak, Joseph F.
    Karas, Richard H.
    Wanke, Christine A.
    CLINICAL INFECTIOUS DISEASES, 2014, 58 (06) : 893 - 900
  • [24] Lipoprotein-Associated Phospholipase A2 Serum Levels in Patients From Different Categories of Cardiovascular Risk
    Nozadze, D. N.
    Sergienko, I. V.
    Balakhonova, T. V.
    Semenova, A. E.
    Vlasik, T. N.
    Kukharchuk, V. V.
    KARDIOLOGIYA, 2014, 54 (03) : 57 - 63
  • [25] Lipoprotein-associated phospholipase A2: a cardiovascular risk predictor and a potential therapeutic target
    Ali, Muzammil
    Madjid, Mohammad
    FUTURE CARDIOLOGY, 2009, 5 (02) : 159 - 173
  • [26] Smoking induces lipoprotein-associated phospholipase A2 in cardiovascular disease free adults: The ATTICA Study
    Tselepis, Alexandros D.
    Panagiotakos, Demosthenes B.
    Pitsavos, Christos
    Tellis, Constantinos C.
    Chrysohoou, Christina
    Stefanadis, Christodoulos
    ATHEROSCLEROSIS, 2009, 206 (01) : 303 - 308
  • [27] The Role of Lipoprotein-Associated Phospholipase A2 (Lp-PLA(2)) in Cardiovascular Disease
    Ikonomidis, Ignatios
    Michalakeas, Christos A.
    Lekakis, John
    Parissis, John
    Anastasiou-Nana, Maria
    REVIEWS ON RECENT CLINICAL TRIALS, 2011, 6 (02) : 108 - 113
  • [28] Lipoprotein-associated Phospholipase A2 and Coronary Heart Disease
    Sofogianni, Areti
    Alkagiet, Stelina
    Tziomalos, Konstantinos
    CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (03) : 291 - 296
  • [29] Lipoprotein-associated phospholipase A2 and the risk of ischemic stroke
    Danihel, L.
    Madarasz, S.
    Blazicek, P.
    Lacko, A.
    Luha, J.
    Lehotska, V
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2018, 81 (03) : 308 - 313
  • [30] Plasma levels of lipoprotein-associated phospholipase A2 are increased in patients with β-thalassemia
    Tselepis, Alexandros D.
    Hahalis, George
    Tellis, Constantinos C.
    Papavasiliou, Eleni C.
    Mylona, Panagiota T.
    Kourakli, Alexandra
    Alexopoulos, Dimitrios C.
    JOURNAL OF LIPID RESEARCH, 2010, 51 (11) : 3331 - 3341
12345